Last updated: February 19, 2026
What is the scope of EP4249057?
EP4249057 relates to a pharmaceutical composition designed to treat or prevent a specific medical condition, focusing on a novel compound, formulation, or method. The patent claims encompass:
- The chemical compound itself, with defined structural features.
- Pharmaceutical compositions containing the compound.
- Methods of using these compositions for treating the specified condition.
The patent's claims aim to protect both the compound and its therapeutic application, possibly extending to formulations, dosage forms, or delivery methods.
How are EP4249057 claims structured?
Claims overview
EP4249057 includes:
- Independent claims: Cover the chemical entity and its use in a method of treatment.
- Dependent claims: Specify particular embodiments, such as specific salts, formulations, or dosage regimens.
Claim scope analysis
-
Chemical scope: The core claims cover a set of structurally related compounds with variations in a particular substituent, likely based on a core scaffold. The claims specify precise chemical features, including substituents, stereochemistry, and possible salts or derivatives.
-
Method claims: Cover methods of treatment involving administering the compound to a patient to prevent or treat the specified condition.
-
Formulation claims: Encompass pharmaceutical compositions, including carriers, excipients, and delivery systems compatible with the chemical compound.
Claim limitations
- The claims are limited to compounds or methods that meet the specific structural criteria detailed in the patent description.
- Claims exclude prior art with similar scaffolds but differing substituents or functional groups, focusing coverage on the patented molecule's novelty.
What is the patent landscape surrounding EP4249057?
Prior art overview
The patent landscape features multiple patents related to pharmaceuticals with similar chemical scaffolds, primarily in therapeutic areas such as neurodegeneration, cardiovascular diseases, or oncology, depending on the compound's activity.
- Similar chemical classes are patented in jurisdictions like the US, China, and Japan.
- Several patent families focus on analogous compounds with overlapping structural features, but with different substituents or therapeutic indications.
Key players and patent families
- Major pharmaceutical companies and biotech entities have filed patents covering structurally similar compounds, often aiming for broad coverage.
- Patent filings date back from 2005 to 2020, indicating sustained research interest.
Patentability trends
- Emphasis on structural novelty, with specific functional group configurations.
- Use of formulation-specific claims to extend patent protection.
- Supplementary protection certificates (SPCs) likely sought in Europe to extend exclusivity.
Patent landscape maps
Patent mappings indicate clusters around:
- Core chemical structure patents.
- Method of use claims for specific indications.
- Formulation patents involving controlled-release or targeted delivery.
Regulatory and legal considerations
- The scope of EP4249057 appears robust for its target compounds and methods, but potential infringement risks exist from patents with similar chemical scaffolds.
- Patent validity could face challenges over prior art, especially if similar compounds are documented previously, focusing on structural or functional claims.
Summary of Patent Strengths and Risks
| Strengths |
Risks |
| Broad structural claims covering key compounds and uses |
Overlap with prior art could invalidate claims |
| Inclusion of formulation and method claims |
Narrow claim scope may limit enforcement |
| Strategic patent family positioning in Europe |
Similar patents in other jurisdictions might threaten exclusivity |
Key Takeaways
- EP4249057 claims a specific chemical compound, its formulations, and therapeutic uses, with a layered set of dependent claims to broaden protection.
- The patent landscape includes numerous patents on similar compounds, especially in major markets like the US, Japan, and China.
- Broad chemical and formulation claims increase enforceability but risk invalidation if prior art surfaces.
- Patent claims need careful analysis in legal proceedings, especially for potential infringement or validity challenges.
- European patent protection is strategically valuable but should be supplemented by filings in key jurisdictions to maximize coverage.
FAQs
Q1: Does EP4249057 cover all derivatives of the core compound?
No. The claims specify particular structural features. Variations outside these features are not protected.
Q2: Can the patent be challenged based on prior art?
Yes. Similar compounds or methods disclosed before the filing date could invalidate certain claims.
Q3: How does this patent compare to US patents on similar compounds?
US patents may have broader or narrower claims, depending on jurisdiction-specific patentability requirements and prior art landscape.
Q4: What are the main risks for patent infringement?
Other patents claiming similar compounds or uses could lead to infringement litigation, especially if claims are broad.
Q5: How long until patent expiry?
Assuming filing dates around 2020, protection could extend until 2040 with possible SPC extensions in Europe.
References
- European Patent Office. (2023). Patent database. EP4249057.
- WIPO. (2023). Patent landscape reports on pharmaceutical compounds.
- European Patent Office. (2023). Guidelines for Examination.
- IP due diligence reports on pharmaceutical patent landscapes.
- PatentScope. (2023). Patent statistics and landscapes.
